Henri Bayle
FounderFounder at NKILT Therapeutics
Houston, Texas, United States
FoundedNKILT Therapeutics
Find your path to Henri
201 people in our graph can introduce you to Henri.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Reid Huber to introduce you to Henri
You →Reid · together at Bellicum Pharmaceuticals, Inc. (2014–2023) →Henri
Ask Jamie Chen to introduce you to Henri
You →Jamie · 4 people · together at Bellicum Pharmaceuticals, Inc. →Henri
Ask Sam Okafor to introduce you to Henri
You →Sam · 7 people · together at Baylor College of Medicine →Henri
Sign up to find every way you can get introduced to Henri
- Your email: the people you already email who know Henri
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Henri
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Henri Bayle is a cofounder of NKILT Therapeutics, Inc., where he serves as Chief Scientific Officer and Chief Development Officer. His work focuses on cellular immunotherapies for cancer, including CAR-T and CAR-NK approaches such as those regulated by small molecules, and he has led discovery programs and translational studies for clinical development. His background spans immunology, molecular biology, chemical biology, cell signaling, and developmental biology across both industry and academia.
Founder at NKILT Therapeutics
Intro paths
In turn, Henri can intro founders to NKILT Therapeutics's investors below.
NKILT Therapeutics's investors · 1
Experience
- NKILT Therapeutics, Inc.Chief Scientific Officer and Chief Development Officercurrent2024 — presentHouston, Texas, United States
- NKILT Therapeutics, Inc.Chief Technology Officer, Chief Development Officer2021 — 2024Houston, Texas, United States
- Bellicum Pharmaceuticals, Inc.Vice President Research2021 — 2023Houston County, Texas, United States
- Bellicum Pharmaceuticals, Inc.Senior Director2018 — 2021Houston, Texas
- Bellicum Pharmaceuticals, Inc.Director2014 — 2018Houston
- Baylor College of MedicineAssistant Professor2007 — 2014Houston, TX
- Stanford University School of MedicineResearch Scientist2001 — 2006Palo Alto, CA
Skills & more
From Henri's professional profile.
Frequently asked questions
- Who is Henri Bayle?
- Henri Bayle is a cofounder of NKILT Therapeutics, Inc., where he serves as Chief Scientific Officer and Chief Development Officer. His work focuses on cellular immunotherapies for cancer, including CAR-T and CAR-NK approaches such as those regulated by small molecules, and he has led discovery programs and translational studies for clinical development. His background spans immunology, molecular biology, chemical biology, cell signaling, and developmental biology across both industry and academia.
- Where does Henri Bayle work?
- Henri Bayle is Founder of NKILT Therapeutics.
- What companies did Henri Bayle found?
- Henri Bayle founded NKILT Therapeutics.
- Where did Henri Bayle go to school?
- Henri Bayle studied at Stanford University School of Medicine (Postdoctoral Fellow, Pathology); Princeton University (Doctor of Philosophy (Ph.D.), Molecular Biology); University of Alberta (Bachelor of Science (B.Sc.), Genetics).
Founder mafias
University of Alberta mafia112
Also came through, then founded or led a company.
Stanford University School of Medicine mafia85
Also came through, then founded or led a company.
Same school
Also attended Stanford University School of Medicine159
+ 153 more
Also attended Princeton University1,027
+ 1,021 more
Also attended University of Alberta213
+ 207 more
Shared employers
Also worked at Bellicum Pharmaceuticals, Inc.5
Also worked at Baylor College of Medicine57
+ 51 more
Also worked at Stanford University School of Medicine202
+ 196 more
















































